Page last updated: 2024-10-19

niacinamide and Leukemia P388

niacinamide has been researched along with Leukemia P388 in 2 studies

nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.

Leukemia P388: An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jayaram, HN1
Smith, AL1
Glazer, RI1
Johns, DG1
Cooney, DA1
Schraufstatter, IU1
Hinshaw, DB1
Hyslop, PA1
Spragg, RG1
Cochrane, CG1

Other Studies

2 other studies available for niacinamide and Leukemia P388

ArticleYear
Studies on the mechanism of action of 2-beta-D-ribofuranosylthiazole-4-carboxamide (NSC 286193)--II. Relationship between dose level and biochemical effects in P388 leukemia in vivo.
    Biochemical pharmacology, 1982, Dec-01, Volume: 31, Issue:23

    Topics: Animals; Antineoplastic Agents; Guanosine; Hypoxanthines; IMP Dehydrogenase; Kinetics; Leukemia P388

1982
Oxidant injury of cells. DNA strand-breaks activate polyadenosine diphosphate-ribose polymerase and lead to depletion of nicotinamide adenine dinucleotide.
    The Journal of clinical investigation, 1986, Volume: 77, Issue:4

    Topics: Adenosine Triphosphate; Animals; Culture Media; DNA; DNA Repair; DNA, Single-Stranded; Enzyme Activa

1986